These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6106577)

  • 1. Paradoxical effect of flavoxate on human uterine contractility in vivo.
    Coutinho EM; Darzé E; Gesteira SK
    Int J Gynaecol Obstet; 1980; 17(6):581-84. PubMed ID: 6106577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological activities of the main metabolite of flavoxate 3-methylflavone-8-carboxylic acid.
    Cazzulani P; Pietra C; Abbiati GA; Ceserani R; Oliva D; Civelli M; Tajana A; Nardi D
    Arzneimittelforschung; 1988 Mar; 38(3):379-82. PubMed ID: 2838033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of flavoxate antispasmodic activity comparative in vitro studies.
    Cazzulani P; Panzarasa R; De Stefani C; Graziani G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):189-200. PubMed ID: 4026456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of naloxone on uterine contractions in patients with primary dysmenorrhea].
    Mrugacz G; Grygoruk C; Sieczyński P; Grusza M; Pietrewicz P; Pietrzycki B
    Pol Merkur Lekarski; 2013 Sep; 35(207):151-3. PubMed ID: 24224452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the effect and mode of action of flavoxate in human urinary bladder and sphincter.
    Pedersen E
    Urol Int; 1977; 32(2-3):202-8. PubMed ID: 906183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting effects of diethylenetriamine-nitric oxide, a spontaneously releasing nitric oxide donor, on pregnant rat uterine contractility in vitro versus in vivo.
    Buhimschi C; Buhimschi I; Yallampalli C; Chwalisz K; Garfield RE
    Am J Obstet Gynecol; 1997 Sep; 177(3):690-701. PubMed ID: 9322644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of resveratrol, a grape polyphenol, on uterine contraction and Ca²+ mobilization in rats in vivo and in vitro.
    Hsia SM; Wang KL; Wang PS
    Endocrinology; 2011 May; 152(5):2090-9. PubMed ID: 21363935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of circulating prostacyclin on contractility of the non-pregnant human uterus.
    Mäkäräinen L; Ylikorkala O
    Br J Obstet Gynaecol; 1982 May; 89(5):402-7. PubMed ID: 7044406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder muscle contractility. Comparative effects and mechanisms of action of atropine, propantheline, flavoxate, and imipramine.
    Benson GS; Sarshik SA; Raezer DM; Wein AJ
    Urology; 1977 Jan; 9(1):31-5. PubMed ID: 831350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibromyomas and uterine contractions.
    Szamatowicz J; Laudanski T; Bulkszas B; Akerlund M
    Acta Obstet Gynecol Scand; 1997 Nov; 76(10):973-6. PubMed ID: 9435739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ge-Gen Decoction attenuates oxytocin-induced uterine contraction and writhing response: potential application in primary dysmenorrhea therapy.
    Yang L; Chai CZ; Yue XY; Yan Y; Kou JP; Cao ZY; Yu BY
    Chin J Nat Med; 2016 Feb; 14(2):124-132. PubMed ID: 26968678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
    Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
    J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of D-(-)-norgestrel on uterine contractility in the puerperium (author's transl)].
    Romero-Salinas G; La Torre-Rasguido F; Vera-Cáceres R; Escalera-Villarreal G; Bandera-Gonzalez B
    Reproduccion; 1981; 5(1):19-29. PubMed ID: 7250483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between oral and vaginal administration of misoprostol on uterine contractility.
    Danielsson KG; Marions L; Rodriguez A; Spur BW; Wong PY; Bygdeman M
    Obstet Gynecol; 1999 Feb; 93(2):275-80. PubMed ID: 9932569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myometrial response to intra-uterine administration of PGF2alpha and PGE2 in dysmenorrheic women.
    Lundström V
    Acta Obstet Gynecol Scand; 1977; 56(3):167-72. PubMed ID: 878858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of flavoxate on uninhibited detrusor contractions and urinary incontinence in the elderly.
    Briggs RS; Castleden CM; Asher MJ
    J Urol; 1980 May; 123(5):665-6. PubMed ID: 7420551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral contraceptives on uterine contractility and menstrual pain: an assessment with cine MR imaging.
    Kido A; Togashi K; Kataoka M; Maetani Y; Nakai A; Kataoka ML; Koyama T; Fujii S
    Hum Reprod; 2007 Jul; 22(7):2066-71. PubMed ID: 17567596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-uterine pressure in dysmenorrhea.
    Lumsden MA; Baird DT
    Acta Obstet Gynecol Scand; 1985; 64(2):183-6. PubMed ID: 3984694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a vasopressin antagonist in women with dysmenorrhea.
    Valentin L; Sladkevicius P; Kindahl H; Broeders A; Marsal K; Melin P
    Gynecol Obstet Invest; 2000; 50(3):170-7. PubMed ID: 11014949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.